Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nanoveu Limited (NVU.AX)
Perth, WA, AU
Nanoveu Limited, an Australian technology company founded in 2018 and based in Subiaco, focuses on inventing and globally marketing nanotechnology-based solutions for consumer electronics. Its current offerings include Nanoshield, an antiviral protective layer that comes as mobile phone screen covers, cases, and a commercial film for diverse surface applications. Another key product, EyeFly3D, enables standard 2D digital displays to render content in 3D without requiring specialized glasses. Additionally, the company is actively developing several new ventures: Customskins vending machines designed for quick and accurate mobile phone screen cover application (taking just over a minute), EyeFyx, a vision correction system using a combination of hardware and software to modify screen output, and an anti-flamatory coating technology intended for plastic laminates within the aviation and transport industries.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.72% | -5.00% | -3.39% | -20.83% | -30.49% | -32.14% | +32.56% | +119.23% | +0.00% | -56.15% | -56.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%+4,229.7% ★ Q4'25: +893.2% (vs Q3'24)
-
EPS growth Software - Application: +28.6%-50.0% Q4'25: -113.6% (vs Q3'24)
-
FCF margin FCF growth · Software - Application: +45.3%-2,432.5% Q4'25: +0.0% (vs Q3'24)
-
EBIT margin Software - Application: +9.4%-2,562.9% Q4'25: -27,842.7% (vs Q3'24)
-
ROIC Software - Application: +7.5%-71.8% Q4'25: -172.6% (vs Q3'24)
-
Share dilution Software - Application: +0.0%+74.4% Q4'25: +114.1% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-0.05× Q4'25: -0.02× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
781.2K
est: 2.10M (-62.8%)
|
159.5K
est: 5.50M (-97.1%)
|
102.5K
est: 7.60M (-98.7%)
|
6.9K
est: 7.60M (-99.9%)
|
2.10M
2.10M – 2.10M
-72.4% YoY
|
5.50M
5.50M – 5.50M
+161.9% YoY
|
7.60M
7.60M – 7.60M
+38.2% YoY
|
| EBITDA |
-1.97M
est: -2.10M (+6.1%)
|
-2.45M
est: -5.50M (+55.4%)
|
-1.98M
est: -7.60M (+74.0%)
|
-2.73M
est: -7.60M (+64.0%)
|
-2.10M
-2.10M – -2.10M
+72.4% YoY
|
-5.50M
-5.50M – -5.50M
-161.9% YoY
|
-7.60M
-7.60M – -7.60M
-38.2% YoY
|
| EBIT |
-2.02M
est: -2.10M (+3.7%)
|
-2.50M
est: -5.50M (+54.6%)
|
-2.15M
est: -7.60M (+71.8%)
|
-2.84M
est: -7.60M (+62.6%)
|
-2.10M
-2.10M – -2.10M
+72.4% YoY
|
-5.50M
-5.50M – -5.50M
-161.9% YoY
|
-7.60M
-7.60M – -7.60M
-38.2% YoY
|
| Net Income |
-2.32M
est: -3.79M (+38.8%)
|
-2.67M
est: -947.3K (-182.2%)
|
-2.16M
est: 473.7K (-556.0%)
|
-2.85M
est: 825.9K (-444.6%)
|
-6.61M
-6.61M – -6.61M
-900.0% YoY
|
-1.65M
-1.65M – -1.65M
+75.0% YoY
|
825.9K
825.9K – 825.9K
+150.0% YoY
|
| SGA |
1.97M
est: 136.20M (-98.6%)
|
2.30M
est: 356.72M (-99.4%)
|
1.54M
est: 492.92M (-99.7%)
|
1.98M
est: 509.64M (-99.6%)
|
140.82M
140.82M – 140.82M
-72.4% YoY
|
368.82M
368.82M – 368.82M
+161.9% YoY
|
509.64M
509.64M – 509.64M
+38.2% YoY
|
| EPS |
-0.01
est: -0.01 (-67.5%)
|
-0.01
est: 0.00 (-480.0%)
|
-0.01
est: 0.00 (-680.0%)
|
-0.01
est: 0.00 (-700.0%)
|
-0.01
-0.01 – -0.01
-900.0% YoY
|
0.00
0.00 – 0.00
+75.0% YoY
|
0.00
0.00 – 0.00
+150.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alfred Chong | MD, Chief Executive Officer & Director | 315.6K | male |
| David Dominic Pevcic MBBS | Executive Chairman | 128.7K | — |
| Siyuan Chen | CFO & Director | 114.2K | male |
| Lin Ruifeng | Chief Operations Officer | — | male |
| Mark Goranson | Chief Executive Officer of Semiconductor Technologies Division | — | male |
| Mory Houshmand | Head of Solar | — | male |
| Tatsuo Shirahama | Chief Technology Officer | — | male |
| Harry Spindler | Company Secretary | — | male |
| Lau Pek Hwee | Head of Manufacturing, Production & Sales - Greater China | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NVU.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
